Publications

Salwan A, Mathis SM, Brooks B, Hagemeier N, Tudiver F, Foster KN, Alamian A, & Pack RP. (2024). A theoretical explanation of naloxone provision among primary care physicians and community pharmacists in Tennessee. Research in Social and Administrative Pharmacy. doi: 10.1016/j.sapharm.2024.07.001

Hogue A, Satcher MF, Drazdowski T, Hagaman A, Hibbard P, Sheidow, AJ, Coetzer-Liversage A, Mitchell SG, Watson DP, Wilson KJ, Muench F, Fishman M, Wenzel K, Castedo de Martell S, & Stein, LAR. (2024). Linkage facilitation services for opioid use disorder: Taxonomy of facilitation practitioners, goals, and activities. Journal of Substance Use and Addiction Treatment, 157, 209-217. doi: 10.1016/j.josat.2023.209217

Hagaman, A., Foster, K., Kidd, M., & Pack, R. (2023). An examination of peer recovery support specialist work roles and activities within the recovery ecosystems of Central Appalachia. Addiction Research & Theory, 31(5), 328–334. https://doi.org/10.1080/16066359.2022.2163387

Cioffi, C. C., Hibbard, P. F., Hagaman, A., Tillson, M., & Vest, N. (2023). Perspectives of researchers with lived experience in implementation science research: Opportunities to close the research-to-practice gap in substance use systems of care. Implementation Research and Practice, 4. https://doi.org/10.1177/26334895231180635

Hagaman, A., Roark, K., & Washburn, L. T. US Cooperative Extension's Response to Substance Misuse: A Scoping Review. Frontiers in Public Health, 11, 320.

Melton, T, Brooks, B, Tudiver, F, Alamian, A, Foster, K, Arnold, J, Pack, R, Hagemeier, N, (2022) Primary Care Physicians’ Opioid-Related Prevention Behaviors and Intentions: A Descriptive Analysis.  Journal of General Internal Medicine.

Warfield SC, Pack RP, Degenhardt L, et al. The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas. Journal of Substance Abuse Treatment. 2021;121:108189.

Salwan, A, Hagemeier, NE, Tudiver, F, Dowling-McClay, K, Foster, K, Arnold, J, Alamian, A, Pack, R. Community Pharmacist Engagement in Opioid Use Disorder Prevention and Treatment Behaviors: A Descriptive Analysis.  Journal of the American Pharmacists Association.  doi: 10.1080/08897077.2017.1365803  

Pack RP, Healton C, Galea S. Maximizing public benefit from opioid settlement resources [published online ahead of print, second quarter of 2020]. Milbank Quarterly. doi: 10.1111/1468-0009.12450

Mathis SM, Hagemeier N, Foster KN, Baker K, Pack RP. "It's Took Over This Region": Patient Perspectives of Prescription Drug Abuse in Appalachia. Subst Use Misuse. 2019:1-11. doi: 10.1080/10826084.2019.1654514 

Ventricelli D, Mathis S, Foster K, Pack R, Tudiver F, Hagemeier NE. Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study. Substance Use & Misuse. doi: 10.1080/10826084.2019.1670210

East Tennessee State University, NORC at the University of Chicago. Health Disparities Related to Opioid Misuse in Appalachia: Practical Strategies and Recommendations for Communities. Appalachian Regional Commission, Foundation for a Healthy Kentucky, Robert Wood Johnson Foundation.

Mathis SM, Hagaman A, Hagemeier N, Baker K, Pack RP. Provider–patient communication about prescription drug abuse: A qualitative analysis of the perspective of prescribers. Substance abuse. 2019:1-11. doi: 10.1016/j.sapharm.2015.12.008

Hagemeier N. The Role of Community Pharmacy in Addressing and Preventing Opioid Use Disorder In: Butler JC, Fraser M, ed. The Public Health Guide to Ending the Opioid Crisis. In Press 2019. doi:10.1093/oso/9780190056810.003.0008

Healton, C, Pack, RP, Galea, S. The Opioid Crisis:  Corporate Responsibility and Lessons Learned from the Tobacco Master Settlement Agreement. JAMA. 2019 No 01. PMID: 31675054. doi: 10.1001/jama.2019.17144 

Poloyac SM, Cavanaugh JE, Hagemeier NE, et al. Breaking Down Barriers to Pharmacy Graduate Education: The Report of the 2017-2018 Research and Graduate Affairs Committee. American journal of pharmaceutical education. 2018;82(7):7147. doi: 10.5688/ajpe7147

Hagemeier NE. Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life. Am J Manag Care. 2018;24(10 Suppl):S200-S206.

Hagemeier N. Patient Communication and Education. In: AHSP Competency Assessment Book. 2018.

Dowling K, Mospan CM, Subedi P, Hagemeier NE. Explaining Pharmacy Students’ Dispensing Intentions in Substance Abuse-Related Gray Areas of Practice Using the Theory of Planned Behavior. American Journal of Pharmaceutical Education. 2018:ajpe6767. doi:10.5688/ajpe6767

Snyder ME, Frail CK, Gernant SA, et al. Fellowships in community pharmacy research: Experiences of five schools and colleges of pharmacy. Journal of the American Pharmacists Association. 2016;56(3):316-322. doi: 10.1016/j.japh.2015.11.015

Horn, KA, Pack, RP, Trestman, R, Lawson, G (2018).  Almost everything we need to better serve children of the opioid crisis we learned in the 80s and 90s.  Frontiers in Public Health, 6:289. https://doi.org/10.3389/fpubh.2018.00289

Mathis, SM, Hagemeier, NE, Hagaman, A, Dreyzehner, J, Pack, RP (2018).  A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States.  Current HIV/AIDS Reports. 15(5) 359-370. doi: 10.1007/s11904-018-0409-9

Wykoff, RW, Pack, RP, Egen O*. (2018) The 12 P’s of the Opioid Epidemic. AJPH. 108, no. 9 (September 1, 2018): pp. 1124-1125. https://doi.org/10.2105/AJPH.2018.304629

Moorman, JP, Krolikowski, MR, Mathis, SM, Pack, RP (2018) HIV/HCV Co-infection:  Burden of disease and care strategies in Appalachia, Current HIV/AIDS Reports. doi: 10.1007/s11904-018-0404-1

Salwan, A.J., Hagemeier, N.E. & Harirforoosh, S. (2018). Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters? Clinical Drug Investigation. 38, 573. doi: 10.1007/s40261-018-0651-3 

Hagemeier, N.E., Click, I.A., Flippin, H, Gilliam H, Basden JA, Carico R, Ross A. (2018).  Pharmacists’ and Prescribers’ Neonatal Abstinence Syndrome (NAS) Prevention Behaviors: A Preliminary Analysis. International Journal of Clinical Pharmacy, 40(1), 20-25 doi: 10.1007/s11096-017-0573-9

Hagemeier, N. E., Tudiver, F., Brewster, S., Hagy, E. J., Ratliff, B., Hagaman, A., & Pack, R. P. (2018). Interprofessional Prescription Opioid Abuse Communication among Prescribers and Pharmacists: A Qualitative Analysis. Substance Abuse, 39(1), 89–94. doi: 10.1080/08897077.2017.1365803

Hagemeier NE, Ventricelli D, Sevak RJ. (2017) Situational communication self-confidence among community pharmacists: A descriptive analysis.  Research in Social and Administrative Pharmacy, 13(6), 1175-1180. doi: 10.1016/j.sapharm.2016.12.003

Brooks, B., McBee, M., Pack, R., & Alamian, A. (2017). The effects of rurality on substance use disorder diagnosis: A multiple-groups latent class analysis. Addictive Behaviors, 68, 24-29. doi: 10.1016/j.addbeh.2017.01.019

Shah, D., Brown, S., Hagemeier, N., Zheng, S., Kyle, A., Pryor, J., … Singh, P. (2016). Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help? SpringerPlus, 5(1), 854. doi: 10.1186/s40064-016-2576-8

Pack, R. P., Hagaman, A., Warfield, S., Gray, J. A., Tudiver, F., Alamian, A., & Hagemeier, N. (2016). Interprofessional Research, Training and Outreach: The ETSU Prescription Drug Abuse/Misuse Working Group. International Journal of Health Sciences Education, 3(2). 

Hagemeier, N. E. (2016). Communicative behavior. In Newton DE ed. Prescription Drug Abuse: A Reference Handbook. Santa Barbara, CA: ABC-CLIO, 136-140.

Hagemeier, N. E., Alamian, A., Murawski, M. M., Flippin, H., Hagy, E. J., & Pack, R. P. (2016). Correlates of Prescription Opioid Legitimacy Judgments Among Community Pharmacists. Subst Use Misuse, 51(6), 692-699. doi: 10.3109/10826084.2015.1135952

Hagemeier, N. E., Alamian, A., Murawski, M. M., & Pack, R. P. (2015). Factors associated with provision of addiction treatment information by community pharmacists. J Subst Abuse Treat, 52, 67-72. doi: 10.1016/j.jsat.2014.11.006

Hagemeier, N. E., Blevins, S. R., Hagen, K. S., Sorah, E. L., Shah, R. S., Ferris, K. M. (2015). Integration of Rural Community Pharmacies into a Rural Family Medicine Practice-Based Research Network: A Descriptive Analysis. Innovations in Pharmacy, 6(3), e1-e11. doi: https://doi.org/10.24926/iip.v6i3.398

Hagemeier, N. E., Tudiver, F., Brewster, S., Hagy, E. J., Hagaman, A., & Pack, R. P. (2015). Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors.Res Social Adm Pharm. doi:10.1016/j.sapharm.2015.12.008 doi: 10.1016/j.sapharm.2015.12.008

Gray, J., Hagemeier, N., Brooks, B., & Alamian, A. (2015). Prescription disposal practices: A 2-Year ecological study of drug drop box donations in Appalachia. Am J Public Health, 105(9), e89-94. doi: 10.2105/AJPH.2015.302689  

Paterson NE, Frank V, Sevak RJ, Wagreich E, London ED. (2014) Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.Am. J. Drug Alcohol Dep. 40: 19 doi: 10.3109/00952990.2013.858723

Hagemeier, N. E., Gray, J. A., & Pack, R. P. (2013). Prescription drug abuse: A comparison of prescriber and pharmacist perspectives.Substance Use & Misuse, 48(9), 761-768. doi: 10.3109/10826084.2013.787101

Hagemeier, N. E., Murawski, M. M., Lopez, N. C., Alamian, A., & Pack, R. P. (2013). Theoretical Exploration of Tennessee Community Pharmacists’ Perceptions Regarding Opioid Pain Reliever Abuse Communication. Research in Social & Administrative Pharmacy. doi: 10.1016/j.sapharm.2013.07.004

Stoops WW, Bennetta JA, Lile JA, Sevak RJ, Rush CR. (2013) Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.Prog. Neuropsychopharmacol. Biol. Psychiatry 47:111-117. doi: 10.1016/j.pnpbp.2013.08.007

Gray, J. A., & Hagemeier, N. E. (2012). Prescription drug abuse and DEA-sanctioned drug take-back events: Characteristics and outcomes in rural Appalachia. Archives of Internal Medicine, 172(15), 1186-1187. doi: 10.1001/archinternmed.2012.2374

Dean AC, Sevak RJ, Monterosso J, London ED. (2011) Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans.J. Stud. Alcohol. Drugs. 72:943-53. doi: 10.15288/jsad.2011.72.943

White, R,  Zullig, KJ, Lander, L, Shockley, C, Pack, RP, Sullivan, CR (2011).Preliminary results of the West Virginia Prescription Drug Abuse Quitline. Health Promotion Practice. Sept 13 2011 epub ahead of print.

Sevak RJ, Vansickel AR, Stoops WW, Hays LR, Rush CR. (2011) Discriminative-stimulus, subject-rated and physiological effects of methamphetamine in humans pretreated with aripiprazole.J. Clin. Psychopharmacology 31(4): 470-480. doi: 10.1097/JCP.0b013e318221b2db

Zullig, KJ, Lander, L, White, RJ, Sullivan, CR, Shockley, C, Dong, L, Pack, RP, Surber Fedis, T (2010)  Preliminary Evaluation of the W V Prescription Drug Abuse Quitline. West Virginia Medical Journal 106, 4, 38-46.

Sevak RJ, Stoops WW, Glaser PAE, Hays LR, Rush CR. (2010) Reinforcing effects of d-amphetamine: Influence of novel ratios on a progressive-ratio schedule. Behav. Pharmacol. 21:745-753. doi: 10.1097/FBP.0b013e32833fa7b3

Sevak RJ, Stoops WW, Rush CR. (2010) Behavioral effects of d-amphetamine in humans: Influence of sub clinical levels of inattention and hyperactivity. Am. J. Drug Alc. Abuse 36:220-227. doi: 10.3109/00952990.2010.494213

Rush CR, Stoops WW, Sevak RJ, Hays LR. (2010) Cocaine choice in humans during d-amphetamine maintenance.J. Clin. Psychopharmacology 30(2):152-159. doi: 10.1097/JCP.0b013e3181d21967

Lanier, MM, Pack, RP & Akers, TA (2010) Epidemiologic Criminology:  Drug use among gang members. Journal of Correctional Health Care. 16:6-16  (erratum in JCHC 16(3) 250. doi: 10.1177/1078345809348199

Sevak RJ, Stoops WW, Hays LR, Rush CR. (2009) Discriminative-stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans J. Pharmacol. Exp. Ther 328(3):1007-1018. doi: 10.1124/jpet.108.147124

Pack, RP, Krishnamurthy, G*, Cottrell L, Stanton BF, D'Alessandri, D*, Burns, J (2005)  Caregiver predictors of adolescent inhalant abuse in rural Appalachia.  American Journal of Health Behavior;  29(4):331-341. doi: https://doi.org/10.5993/AJHB.29.4.5

Burns, J, Cottrell, L, Perkins, K, Pack, RP, Stanton, BF, Hobbs, G, Hobby, L, Eddy, D, Hauschka, A (2004) Depressive symptoms and risk behaviors among rural adolescents. Pediatrics 113(5),1313-1320. doi: 10.1542/peds.113.5.1313  

Rai, A.A., Stanton, B., Wu, Y., Li, X., Galbraith, J., Cottrell, L., Pack, R., Harris, C., D'Alessandri, D., & Burns, J. (2003). The relative influences of perceived parental monitoring and perceived peer involvement on adolescent risk behaviors: An analysis of six cross-sectional data sets. Journal of Adolescent Health, 33(2)  108-118. https://doi.org/10.1016/S1054-139X(03)00179-4

Stanton, BF,Li, X, Pack, RP, Cottrell, L, Harris, CA, Burns, JM (2002). Longitudinal influence of perceptions of peer and parental factors on African American adolescent risk involvement. Journal of Urban Health, 79(4); 536-548. doi: 10.1093/jurban/79.4.536  

Li, X, Stanton, BF, Pack, RP, Harris, CA, Cottrell, L & Burns, J (2002) Risk and Protective factors associated with gang involvement among urban African-American children and adolescents.  Youth and Society, 34(2); 172-194. https://doi.org/10.1177/004411802237862

Pack, RP, Crosby, RA, St. Lawrence, JS (2001) Associations between adolescents risk behavior and their scores on six psychometric scales.  Journal of HIV/AIDS Prevention and Education for Adolescents and Children 4(1) 33-47. https://doi.org/10.1300/J129v04n01_04

Li, X, Stanton, BF, Cottrell, L, Burns, J, Pack, RP, Kaljee, L (2001) Patterns of initiation of sex and drug-related activities among urban low-income African-American adolescents. Journal of Adolescent Health 28(1), 46-54. doi: 10.1016/s1054-139x(00)00173-7

Zorick T, Sevak RJ, Swanson AM, Miotto K, De La Garza R, Newton T, Shoptaw SS, London ED. (2009) Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J. Exp. Pharmacol. 2:13-18.

Stanton, B, Harris, C, Cottrell, L, Li, X, Gibson, C, Guo, J, Pack, RP, Galbraith, J, Pendleton, S, Wu, Y, Marshall, S (2006) Trial of an urban adolescent risk reduction program for rural youth:  An imperfect fit.  Journal of Adolescent Health.  38(1):55. https://doi.org/10.1016/j.jadohealth.2004.09.023

Stanton, B, Guo, J, Cottrell, L, Galbraith, J, Li, X, Gibson, C, Pack, R,  Cole, M, Marshall, S Harris, C (2005) The complex business of adapting effective interventions to new populations: an urban to rural transfer  Journal of Adolescent Health  37(163):17- 26. doi: https://doi.org/10.1016/j.jadohealth.2004.10.005

Li, X, Stanton, BF, Galbraith, J, Burns, J, Cottrell, L, Pack, RP (2002). Parental monitoring intervention: Practice makes perfect.  Journal of the National Medical Association 94(5):364-70